Table 1.
Characteristics of the study group of hospital employees.
| TOTAL, N (%) | |
|---|---|
| SEX: | 354 |
| MALE | 65 (18) |
| FEMALE | 289 (82) |
| PAST COVID-19 INFECTION | 161 (45) |
| COURSE OF INFECTION: | 158 |
| ASYMPTOMATIC | 37 (23) |
| SYMPTOMATIC, HOME TREATMENT | 111 (70) |
| SYMPTOMATIC, HOSPITALISATION | 10 (7) |
| SUBJECT CATEGORY | |
| ADMINISTRATION | 33 (9) |
| PHYSIOTHERAPIST | 10 (3) |
| NON-SURGEON | 74 (21) |
| SURGEON | 19 (6) |
| NURSE/PARAMEDIC/CARER | 152 (43) |
| LABORATORY ASSISTANT/PHARMACIST | 55 (15) |
| WARD ATTENDANTS/STRETCHER-BEARERS | 11 (3) |
| SMOKING | 350 |
| NO | 292 (83) |
| YES | 58 (17) |
| BLOOD TYPE | 319 |
| 0 | 108 (34) |
| A | 117 (37) |
| B | 69 (21) |
| AB | 25 (8) |
| VAE 1 | |
| 0–5 | 237 (67) |
| 6–10 | 60 (17) |
| >10 | 57 (16) |
| VAE 2 | |
| 0–5 | 184 (52) |
| 6–10 | 86 (24) |
| >10 | 84 (24) |
| CHRONIC DISEASES: | 111 (31) |
| RENAL DISEASES | 2 (0.6) |
| CARDIOVASCULAR DISEASES HYPERTENSION HYPERCHOLESTEROLAEMIA |
36 (10) 11 (9.9) 2 (0.6) |
| LUNG DISEASES ASTHMA CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
6 (1.7) 3 (0.8) 3 (0.8) |
| CONNECTIVE TISSUE DISEASES | 4 (1.1) |
| OSTEOPOROSIS | 3 (0.8) |
| SKIN PSORIASIS | 3 (0.8) |
| SARCOIDOSIS | 1 (0.3) |
| NEUROLOGICAL DISEASES | 5 (1.4) |
| HASHIMOTO’S DISEASE | 31 (9) |
| THYROID NODULES | 3 (0.8) |
| DIABETES MELLITUS | 5 (1.4) |
| INSULIN RESISTANCE | 2 (0.6) |
| GLAUCOMA | 1 (0.3) |
| ALLERGY | 7 (2.0) |
| ENDOMETRIOSIS | 2 (0.6) |
Abbreviations: VAE—vaccine adverse event; VAE1—vaccine adverse event after the first dose; VAE2—vaccine adverse event after the second dose; N—number of patients; %—percent of patients.